| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8447670 | European Journal of Cancer | 2011 | 8 Pages |
Abstract
Omeprazole 40Â mg did not alter the pharmacokinetics and toxicities of irinotecan. This widely used drug can, therefore, be safely administered during a 3-weekly single agent irinotecan schedule.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jessica M. van der Bol, Walter J. Loos, Floris A. de Jong, Esther van Meerten, Inge R.H.M. Konings, Mei H. Lam, Peter de Bruijn, Erik A.C. Wiemer, Jaap Verweij, Ron H.J. Mathijssen,